Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to publish data on the uptake of the HIV prevention drug PrEP; and whether that data will be broken down by (a) key population groups at risk of HIV and (b) region.

The deployment of routine pre-exposure prophylaxis (PrEP) began in England in autumn 2020. The UK Health Security Agency (UKHSA) is analysing data on the uptake of PrEP among different population groups in various geographical regions. The GUMCAD STI Surveillance System collects data on PrEP eligibility, offer and use and the number of tablets prescribed. Data on PrEP need and use will be published in routine sexually transmitted infections and HIV surveillance data. A phased approach to publication will take place starting later this year after a full year of data for 2021 has been reported to the UKHSA. Where possible and depending on the intended publication, the indicators will be presented by key population group and geographical region.